Q1 2026 · 13F-HR
Atle Fund Management ABholdings as filed
Filed 2026-05-11 · accession 0001381843-26-000004
$309.7M
Reported value
39
Positions
2026-03-31
Period end
The Brief · Atle Fund Management AB · Q1 2026
AI · grounded in 13F
Atle Fund Management AB established a new position in JNJ worth $11.9M. The fund also opened new stakes in EW for $8.3M and TNGX for $3.6M. To fund these moves, the manager closed its position in UFPT, reducing exposure by $5.1M, and exited ACLXGBX for $2.7M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 532457108 | LLY | ELI LILLY & CO | $26.8M | 8.67% | 39,722 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO. INC | $22.9M | 7.40% | 33,853 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC CORP | $14.4M | 4.67% | 22,986 | Common | SOLE |
| 07725L102 | ONC | BEONE MEDICINES LTD-ADR | $12.1M | 3.92% | 41,717 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $11.9M | 3.86% | 92,377 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $11.9M | 3.84% | 111,363 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $11.2M | 3.61% | 22,984 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $10.4M | 3.35% | 108,181 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $9.6M | 3.09% | 26,835 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $9.4M | 3.05% | 70,851 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $9.4M | 3.03% | 27,873 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $9.4M | 3.03% | 195,768 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $9.3M | 2.99% | 23,773 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $9.1M | 2.93% | 617,245 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $8.8M | 2.86% | 40,432 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $8.7M | 2.81% | 21,903 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $8.3M | 2.67% | 106,518 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $8.2M | 2.66% | 242,473 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $8.0M | 2.57% | 50,796 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $7.9M | 2.54% | 89,685 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $7.2M | 2.31% | 47,967 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH, INC | $6.8M | 2.19% | 37,579 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $6.6M | 2.13% | 23,470 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $6.3M | 2.02% | 22,322 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.0M | 1.92% | 97,438 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $5.5M | 1.78% | 94,796 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $5.1M | 1.66% | 141,296 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $4.8M | 1.54% | 31,590 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $4.8M | 1.54% | 108,682 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $4.0M | 1.30% | 31,133 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $3.6M | 1.17% | 29,915 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $3.5M | 1.13% | 62,735 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.2M | 1.03% | 107,255 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $3.1M | 0.99% | 41,831 | Common | SOLE |
| 91324P102 | UNH | UNIVERSAL HEALTH SERVICES INC | $2.8M | 0.90% | 14,636 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $2.6M | 0.85% | 584,332 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $2.3M | 0.75% | 1,169,634 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $2.2M | 0.71% | 90,184 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $1.6M | 0.52% | 197,036 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.